Personal tools
You are here: Home Know-who Know-how Directory From A to Z XenoBiosis International B.V.
Document Actions

XenoBiosis International B.V.

Business focus: A company that develops and manufactures biologically active compounds of plant origin for the pharmaceutical, functional foods and cosmetic industry.

XenoBiosis

XenoBiosis International B.V.
Platinastraat 33
8211 AR Lelystad
Website XenoBiosis International B.V.
E-mail XenoBiosis International B.V.
T +31 (0)320 28 63 33
F +31 (0)320 28 69 86

Employees in Amsterdam: 15
Employees in R&D: 3
Year of foundation: 2006

Company profile

XenoBiosis has established unique technologies and know-how enabling it to extract isolate and identify active components from complex biological mixtures. The company has a patented industrial technology and additional know-how for extracting and upgrading extracts from plant material. In a sales and lease back construction XenoBiosis has built a multi-purpose production site in Lelystad (The Netherlands).
With its superior Ginkgo extract, selling in a business to business model, XenoBiosis has by the end of 2009 a perfect cash-cow for further development. Ginkgo has an established market, easy to penetrate. XenoBiosis has a Ginkgo leaf drying production facility in China as a Joint Venture, that for the major part will be funded locally.
XenoBiosis’s key persons involved in this project have years of experience in both pharmaceutical development and the international field of business.
XenoBiosis has the know-how for product development up and including pharmaceutical development where it will make use of internal capacity and specialized capacities from its huge international network of institutes and scientists. XenoBiosis has or has access to a huge portfolio of new possible products for the pipe-line.

Science and Technologies or Services

As former head of Bioanalysis, Metabolism and Biochemistry within a multinational pharmaceutical industry, the CEO has designed several technologies enabling very efficient metabolism studies and nature of residue studies. Two of these technologies are patented.
Besides these analytical and preparative techniques also industrial extraction technologies have been developed. One spin-off product of this industrial technology is a new supererior Ginkgo extract, GinkgoTerp, at 95% purity level.

Alliances

XenoBiosis is a stand-alone company with a well-established network of universities and scientific institutes.

Keywords

  • GinkgoTerp;
  • 95% purity;
  • Cosmetics;
  • Functional Foods;
  • Pharmaceuticals;
  • Fine biochemicals.

Powered by Plone CMS, the Open Source Content Management System

This site conforms to the following standards: